Pharmacokinetics of huperzine A following oral administration to human volunteers
- 196 Downloads
The objective of the present study was to investigate the in vivo pharmacokinetics of huperzine A in healthy human volunteers. Twelve subjects (M 6, F 6; age ranged from 20 ∼ 25 years) participated in the study. Huperzine A was administered in tablet form at a single dose of 0.4 mg. Following oral administration, the presence of huperzine A started to appear in the plasma at 5—10 min, and reached the peak concentrations with a Cmax of 2.59±0.37 ng/ml at 58.33±3.89 min (time to reach peak level, Tmax). The area under plasma vs time curve (AUC0−t) and the area under plasma from zero to infinity (AUC0−∞) for huperzine A were found to be 1986.96± 164.57 μg/1-min and 2450.34±233.32 μg/1-min, respectively. The results of this study indicated that the pharmacokinetics of huperzine A conformed to a two-compartmental open model. The mean values of α and the β half-life were 21.13±7.28 min and 716.25±130.18 min respectively, and snowed a biphasic profile with rapid distribution followed by a slower elimination rate.
Key wordsHuperzine pharmacokinetics human plasma
Unable to display preview. Download preview PDF.
- 2.Tang X.C., Han Y.F., Chen X.P., Zhu X.D., (1986): Effects of huperzine A on learning and retrieval processes of discrimination performance in rats. Acta Pharmacol. Sin. 7, 507–511.Google Scholar
- 6.Qian B.C., Wang M., Zhou Z.F., (1995): Pharmacokinetics of tablet huperzine A in six volunteers. Acta Pharmacol. Sin. 16, 396–398.Google Scholar
- 7.Wang Y.E., Feng J., Lu W.H., (1988): Pharmaceutics of huperaine A in rat and mice. Acta Pharmacol. Sin. 9, 193–197.Google Scholar
- 9.Yue P., Zhao Y., Tao T., (2005): Determination of hupezine A in cerebrospinal fluid of rats by HPLC-Fluorescence. Zhongguo Yaoxue Zazhi. 40, 1503–1507.Google Scholar